[Fulminant hepatitis B as a result of reactivation in hematologic patient after chemotherapy combined with rituximab]

MeSH terms

• Aged
• Antibodies, Monoclonal, Murine-Derived / adverse effects*
• Antibodies, Monoclonal, Murine-Derived / therapeutic use
• Antineoplastic Agents / adverse effects*
• Antineoplastic Agents / therapeutic use
• Hematologic Neoplasms / complications*
• Hematologic Neoplasms / drug therapy
• Hepatitis B / etiology*
• Hepatitis B / physiopathology
• Humans
• Lymphoma, B-Cell / complications*
• Lymphoma, B-Cell / drug therapy
• Male
• Rituximab